Humanized PD-L1 tumor cell line, animal model with same and application of humanized PD-L1 tumor cell line and animal model

A technology of PD-L1 and tumor cells, applied in the field of biomedicine, can solve the problems of long time-consuming and high cost of humanized mice, achieve strong killing and proliferation ability, and reduce economic expenditure

Active Publication Date: 2016-09-21
SUZHOU INST OF SYST MEDICINE
View PDF2 Cites 36 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This type of method plays a very important role in the preclinical drug evaluation process, but there are also many shortcomings. The first point is that the establishment of humanized mice is not only time-consuming but also relatively expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Humanized PD-L1 tumor cell line, animal model with same and application of humanized PD-L1 tumor cell line and animal model
  • Humanized PD-L1 tumor cell line, animal model with same and application of humanized PD-L1 tumor cell line and animal model
  • Humanized PD-L1 tumor cell line, animal model with same and application of humanized PD-L1 tumor cell line and animal model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0047] Knockout of murine PD-L1 and expression of human PD-L1 in colon cancer cells MC-38.

[0048] Studies have shown that PD-L1 expressed on the surface of tumor cells in tumor tissue acts as an anti-tumor suppressor molecule 20 . This discovery prompted us to establish a more direct and economical animal model. The method of establishing the model is as follows: figure 1 Shown:

[0049] Step 1: Knock out mouse-derived PD-L1 (mPD-L1) through CRISPR-Cas9: According to CRISPR-Cas9 technology, first design a short-chain guide RNA (sgRNA) through the http: / / crispr.mit.edu website , the design sequence is as follows: 5'-GCTTGCGTTAGTGGTGTACT-3'. The synthesized DNA duplex was inserted into the sgRNA expression vector (FG-BB-U6-sgRNA) through BbsI. Then co-transfect MC-38 cells with the Cas9 expression plasmid (FG-hEF / HTLV-Cas9-PGK-Puro-WPRE), and select with puro for 48 hours after 48 hours.

[0050]Then expand the culture, obtain the knockout cell bank, extract the DNA and p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a humanized PD-L1 tumor cell line MC-38-hPD-L1, a builtanimal tumor model with the same and a method for constructing the humanized PD-L1 tumor cell line. The method particularly includes knocking out animal-origin PD-L1 by the aid of CRISPR-CAS9; carrying out amplification and cultivation to obtain knocked-out cell banks; extracting DNA (deoxyribonucleic acid) and carrying out PCR (polymerase chain reaction) amplification; recycling and cloning amplification products; carrying out over-expression on human-origin PD-L1 in MC-38 cell lines of mPD-L1 KO by the aid of lentivirus systems; packaging lentivirus and screening Puromycin to obtain the humanized MC-38 cell line of PD-L1. The humanized PD-L1 tumor cell line, the animal tumor model and the method have the advantages that as shown by results, high killing efficiency and multiplication capacity are obviously presented by tumor infiltration CD8 T lymphocytes after antibody treatment is carried out, tumor infiltration Treg cells can be obviously inhibited after antibody treatment is carried out, and accordingly the method is proved to be effective and feasible from the aspect of molecular mechanisms.

Description

technical field [0001] The invention relates to a humanized PD-L1 cell line for evaluating the curative effect of PD-L1 antibody, a mouse model with the cell line, and a preparation method of the cell line and the model, belonging to the technical field of biomedicine. Background technique [0002] In recent years, targeted therapy and immunotherapy have increasingly become new strategies for tumor treatment. Immunotherapy, which specifically blocks immune nodes, has gradually become the mainstream of treatment, and has achieved exciting curative effects. The way to specifically block the immune node is mainly to apply the monoclonal antibody that can directly block the immune node. To sum up, now there are mainly killer T lymphocyte antigen 4 (CTLA-4) 1,2 , Programmed cell death protein 1 (PD-1) 3-7 and programmed cell death ligand 1 (PD-L1) 8-12 , These several kinds of immunoregulatory molecules can provide negative control signals to T lymphocytes, thereby inhibiting...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/867C12N15/12A01K67/027A61K49/00A61K39/395A61P35/00
CPCA01K67/027A01K2227/105A01K2227/107A01K2267/0331A61K49/0008A61K2039/505C07K14/705
Inventor 秦晓峰黄安飞彭迪
Owner SUZHOU INST OF SYST MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap